The STD Diagnostics Market has shown significant growth, valued at USD 9.35 billion in 2022. Projections suggest further expansion, with expectations reaching USD 16.06 billion by 2030. This growth reflects the increasing prevalence of sexually transmitted diseases (STDs) worldwide and the growing demand for accurate and accessible diagnostic tests. With an anticipated compound annual growth rate (CAGR) of 7% over the forecast period from 2023 to 2030, the market is poised for steady development, driven by factors such as increasing awareness, changing sexual behaviors, and efforts to control the spread of STDs through early detection and intervention strategies.